Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy (Q36752233)

16 August 2017

1 reference

title

Disorders of immune reconstitution in patients with HIV infection responding to antiretroviral therapy (English)

1 reference

16 August 2017

anti-retroviral agent

0 references

Martyn A French

1

0 references

publication date

1 February 2007

1 reference

16 August 2017

Current HIV/AIDS reports

1 reference

16 August 2017

4

1 reference

16 August 2017

16-21

1 reference

16 August 2017

1

1 reference

https://scigraph.springernature.com/pub.10.1007/s11904-007-0003-z

16 August 2017

0 references

cites work

Association of increased hepatitis C virus (HCV)-specific IgG and soluble CD26 dipeptidyl peptidase IV enzyme activity with hepatotoxicity after highly active antiretroviral therapy in human immunodeficiency virus-HCV-coinfected patients

1 reference

12 December 2020

Characteristics, Determinants, and Clinical Relevance of CD4 T Cell Recovery to <500 Cells/ L in HIV Type 1--Infected Individuals Receiving Potent Antiretroviral Therapy

1 reference

12 December 2020

Intraocular viral and immune pathogenesis of immune recovery uveitis in patients with healed cytomegalovirus retinitis

1 reference

12 December 2020

Lymphatic tissue fibrosis is associated with reduced numbers of naive CD4+ T cells in human immunodeficiency virus type 1 infection.

1 reference

12 December 2020

Explosion of tuberculin-specific Th1-responses induces immune restoration syndrome in tuberculosis and HIV co-infected patients

1 reference

12 December 2020

Graves disease: an increasingly recognized immune reconstitution syndrome

1 reference

12 December 2020

Evidence base for using corticosteroids to treat HIV-associated immune reconstitution syndrome

1 reference

12 December 2020

Long-Term Follow-Up of HIV-Infected Individuals Who Have Significant Increases in CD4+ Cell Counts during Antiretroviral Therapy

1 reference

12 December 2020

Immunopathology as a result of highly active antiretroviral therapy in HIV-1-infected patients

1 reference

12 December 2020

Determinants of CD4+ T cell recovery during suppressive antiretroviral therapy: association of immune activation, T cell maturation markers, and cellular HIV-1 DNA.

1 reference

12 December 2020

The immunopathogenesis of mycobacterial immune restoration disease

1 reference

12 December 2020

Immune restoration disease after antiretroviral therapy

1 reference

12 December 2020

Compartmentalization of the immune response in varicella zoster virus immune restoration disease causing transverse myelitis

1 reference

12 December 2020

Recovery of CD4+ T Cells in HIV patients with a stable virologic response to antiretroviral therapy is associated with polymorphisms of interleukin-6 and central major histocompatibility complex genes.

1 reference

12 December 2020

Sarcoidosis in HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Incidence and risk factors of immune reconstitution inflammatory syndrome complicating HIV-associated cryptococcosis in France

1 reference

12 December 2020

Immune reconstitution cryptococcosis after initiation of successful highly active antiretroviral therapy

1 reference

12 December 2020

Graves' disease during immune reconstitution after highly active antiretroviral therapy for HIV infection: evidence of thymic dysfunction.

1 reference

12 December 2020

Polymorphisms in cytokine genes define subpopulations of HIV-1 patients who experienced immune restoration diseases

1 reference

12 December 2020

Multiparameter evaluation of human thymic function: interpretations and caveats

1 reference

12 December 2020

Long-term outcomes among antiretroviral-naive human immunodeficiency virus-infected patients with small increases in CD4+ cell counts after successful virologic suppression

1 reference

12 December 2020

Mechanisms Involved in the Low‐Level Regeneration of CD4+Cells in HIV‐1–Infected Patients Receiving Highly Active Antiretroviral Therapy Who Have Prolonged Undetectable Plasma Viral Loads

1 reference

12 December 2020

Fulminant inflammatory leukoencephalopathy associated with HAART-induced immune restoration in AIDS-related progressive multifocal leukoencephalopathy

1 reference

12 December 2020

T Cell Activation Is Associated with Lower CD4+T Cell Gains in Human Immunodeficiency Virus–Infected Patients with Sustained Viral Suppression during Antiretroviral Therapy

1 reference

12 December 2020

Low CD4+ T-cell counts in HIV patients receiving effective antiretroviral therapy are associated with CD4+ T-cell activation and senescence but not with lower effector memory T-cell function.

1 reference

12 December 2020

Genetic polymorphisms of Fas (CD95) and Fas ligand (CD178) influence the rise in CD4+ T cell count after antiretroviral therapy in drug-naïve HIV-positive patients

1 reference

12 December 2020

Immune restoration disease after the treatment of immunodeficient HIV-infected patients with highly active antiretroviral therapy

1 reference

12 December 2020

Incidence of immune reconstitution syndrome in HIV/tuberculosis-coinfected patients after initiation of generic antiretroviral therapy in India

1 reference

12 December 2020

Immune reconstitution disease associated with mycobacterial infections in HIV-infected individuals receiving antiretrovirals

1 reference

12 December 2020

Mortality of HIV-1-infected patients in the first year of antiretroviral therapy: comparison between low-income and high-income countries

1 reference

12 December 2020

Determinants of immune reconstitution inflammatory syndrome in HIV type 1-infected patients with tuberculosis after initiation of antiretroviral therapy

1 reference

12 December 2020

Incidence and risk factors for immune reconstitution inflammatory syndrome in an ethnically diverse HIV type 1-infected cohort

1 reference

12 December 2020

Systemic and discoid lupus erythematosus in HIV-infected patients treated with highly active antiretroviral therapy

1 reference

12 December 2020

Features of 'CD4-exploders', HIV-positive patients with an optimal immune reconstitution after potent antiretroviral therapy.

1 reference

12 December 2020

Kaposi's sarcoma-associated herpesvirus induction of AP-1 and interleukin 6 during primary infection mediated by multiple mitogen-activated protein kinase pathways

1 reference

12 December 2020

Early mortality among adults accessing a community-based antiretroviral service in South Africa: implications for programme design

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy

1 reference

12 December 2020

Inflammatory reactions in progressive multifocal leukoencephalopathy after highly active antiretroviral therapy.

1 reference

12 December 2020

Naïve T-cell dynamics in human immunodeficiency virus type 1 infection: effects of highly active antiretroviral therapy provide insights into the mechanisms of naive T-cell depletion

1 reference

12 December 2020

Nontuberculous mycobacterial immune reconstitution syndrome in HIV-infected patients: spectrum of disease and long-term follow-up

1 reference

12 December 2020

The role of immune reconstitution inflammatory syndrome in AIDS-related Cryptococcus neoformans disease in the era of highly active antiretroviral therapy

1 reference

12 December 2020

Thymic function in severely immunodeficient HIV type 1-infected patients receiving stable and effective antiretroviral therapy

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome associated with Kaposi's sarcoma

1 reference

12 December 2020

Guillain‐Barre Syndrome Associated with Immune Reconstitution

1 reference

12 December 2020

Mortality and causes of death in adults receiving highly active antiretroviral therapy in Senegal: a 7-year cohort study

1 reference

12 December 2020

Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis

1 reference

12 December 2020

Herpes zoster as an immune reconstitution disease after initiation of combination antiretroviral therapy in patients with human immunodeficiency virus type-1 infection

1 reference

12 December 2020

Levels of IL-6 and soluble IL-6 receptor are increased in HIV patients with a history of immune restoration disease after HAART

1 reference

12 December 2020

Tegumentary leishmaniasis as a manifestation of immune reconstitution inflammatory syndrome in 2 patients with AIDS.

1 reference

12 December 2020

Regulatory T cells: friend or foe in immunity to infection?

1 reference

12 December 2020

Progressive multifocal leucoencephalopathy with unusual inflammatory response during antiretroviral treatment

1 reference

12 December 2020

Clinical and epidemiologic characterization of photosensitivity in HIV-positive individuals.

1 reference

12 December 2020

MHC haplotypes affect the expression of opportunistic infections in HIV patients

1 reference

12 December 2020

Safe Interruption of Maintenance Therapy against Previous Infection with Four Common HIV-Associated Opportunistic Pathogens during Potent Antiretroviral Therapy

1 reference

12 December 2020

Immune reconstitution inflammatory syndrome in HIV-infected patients with disseminated histoplasmosis

1 reference

12 December 2020

Characteristics of autoimmune thyroid disease occurring as a late complication of immune reconstitution in patients with advanced human immunodeficiency virus (HIV) disease

1 reference

12 December 2020

Cytomegalovirus (CMV) Retinitis Immune Restoration Disease Occurs during Highly Active Antiretroviral Therapy–Induced Restoration of CMV‐Specific Immune Responses within a Predominant Th2 Cytokine Environment

1 reference

12 December 2020

Cytomegalovirus (CMV)-specific CD8+ T cells in individuals with HIV infection: correlation with protection from CMV disease.

1 reference

12 December 2020

10.1007/S11904-007-0003-Z

Identifiers

DOI

1 reference

16 August 2017

1 reference

PubMed ID

17338856